Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
CEO and Co-Founder, Tamr
Managing Director, D.E. Shaw and Co., L.P.
Founder and CEO, Lighter Capital
This symposium will cover new technologies being used to profile the causes of human disease, including advances in quantitative proteomics, clinical screening data, and new biotech developments that may make personalized medicine a reality. Speakers include Charles Cantor of Sequenom and Mark Ladanyi of Memorial Sloan-Kettering Cancer Center. Register here.